PDI swab receives market authorization

Share this content:

Investigators have released results from the first, randomized, crossover, prospective, comparative effectiveness clinical study evaluating the benefits of a 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol over 70% Isopropyl Alcohol alone in disinfecting needleless connectors, PDI announced.

The results concluded that CHG and alcohol scrub meant less needless connecter contamination than an alcohol scrub at a five-second scrub time, the company said. Prevantics® Device Swab from PDI, is the only 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol solution that has received market authorization from the U.S. Food and Drug Administration for disinfecting needleless access sites prior to use.

The results were presented at the 2014 IDWeek Conference in Philadelphia on Oct. 11.

“This study answers a previously unknown clinical question about the most efficacious antiseptic for disinfection of needleless access sites and also ideal prep times,” said Hudson Garrett, Ph.D., vice president of clinical affairs for PDI. “This study demonstrates the importance of targeted efforts to reduce contamination on needleless access sites and ensure evidence-based practices for disinfection of needleless access sites.”


Next Article in Products